EUVIMEDEUVIMED entdecken
Crossref

Real-Time Intrafraction Motion Management in Magnetic Resonance Imaging-Guided Adaptive Radiotherapy and Its Impact on Treatment Precision

Manar Salah, Ahmed Shawky, Eman Gamal, Eman Helmy, Alaa Shawkat, Rasha Adel Abdelmoneum

Integrated Oncology Diagnostics & Treatment · 01.11.2026 · 1 (2) · 108-124

DOI: 10.67692/iodt.26.7900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Integrated Oncology Diagnostics & Treatment, online erschienen am 01.11.2026. Verfasst von Manar Salah und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose: Intrafraction motion remains a principal source of geometric uncertainty in external beam radiotherapy. Magnetic resonance imaging-guided adaptive radiotherapy (MRgART) uses continuous soft-tissue visualization throughout beam delivery to directly manage this uncertainty. This review critically evaluated the current state of real-time intrafraction motion management in MRgART, with emphasis on technological mechanisms, site-specific motion characteristics, clinical strategies, and the available evidence base. Materials and Methods: A structured narrative review of peer-reviewed literature, prospective registries, and international consensus documents published through March 2026 was conducted. PubMed/MEDLINE was searched using terms encompassing MR-Linac platforms, intrafraction motion, real-time gating, and adaptive radiotherapy. A total of 47 references meeting pre-specified inclusion criteria were synthesized.

Results

Two commercial MR-Linac platforms dominated clinical practice: the 1.5 T system (>150 installed units) and the 0.35 T system (~55–65 operational units following corporate restructuring in 2024). Real-time beam gating reduced mean two-dimensional target displacement from 8.3 ± 4.3 mm (ungated) to 1.6 ± 0.6 mm (gated). A phase III randomized trial demonstrated that magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer halved two-year late genitourinary toxicity compared with computed tomography-guided treatment (27% vs 51%; p = 0.004). A multi institutional phase II trial established that ablative pancreatic stereotactic body radiotherapy (50 Gy in 5 fractions) was deliverable with near-zero severe gastrointestinal toxicity and a median overall survival of 22.8 months from diagnosis. Artificial intelligence approaches achieved sub millimeter target localization at inference times of 8–36 milliseconds.

Conclusions

Magnetic resonance imaging-guided intrafraction motion management was selectively transformative, enabling treatments previously limited by geometric uncertainty. Expansion of randomized evidence beyond prostate cancer, resolution of workflow efficiency constraints, and clinical deployment of artificial intelligence-assisted real time tracking represented the field’s foremost priorities.

Zitieren

APA

Salah, M., Shawky, A., Gamal, E., Helmy, E., Shawkat, A., & Abdelmoneum, R. A. (2026). Real-Time Intrafraction Motion Management in Magnetic Resonance Imaging-Guided Adaptive Radiotherapy and Its Impact on Treatment Precision. Integrated Oncology Diagnostics & Treatment, 1(2), 108-124. https://doi.org/10.67692/iodt.26.7900

Vancouver

Salah M, Shawky A, Gamal E, Helmy E, Shawkat A, Abdelmoneum RA. Real-Time Intrafraction Motion Management in Magnetic Resonance Imaging-Guided Adaptive Radiotherapy and Its Impact on Treatment Precision. Integrated Oncology Diagnostics & Treatment. 2026;1(2):108-124. doi:10.67692/iodt.26.7900

BibTeX
@article{Salah2026,
  author = {Salah, Manar and Shawky, Ahmed and Gamal, Eman and Helmy, Eman and Shawkat, Alaa and Abdelmoneum, Rasha Adel},
  title = {Real-Time Intrafraction Motion Management in Magnetic Resonance Imaging-Guided Adaptive Radiotherapy and Its Impact on Treatment Precision},
  journal = {Integrated Oncology Diagnostics & Treatment},
  year = {2026},
  volume = {1},
  number = {2},
  pages = {108--124},
  doi = {10.67692/iodt.26.7900}
}
Kostenlos starten →